A Phase 1 Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy.
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2017
At a glance
- Drugs SB 01 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors SynCore Biotechnology
- 18 Oct 2017 Status changed from active, no longer recruiting to completed.
- 02 Jun 2017 Results (n=33), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 09 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History